Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study

作者全名："Li, Junnan; Tang, Xiaoqiong; Luo, Xiaohua; Liu, Lin; Li, Dan; Yang, Li"

作者地址："[Li, Junnan; Tang, Xiaoqiong; Luo, Xiaohua; Liu, Lin; Yang, Li] Chongqing Med Univ, Dept Hematol, Affiliated Hosp 1, 1 You Yi Rd, Chongqing 400016, Peoples R China; [Li, Dan] Chongqing Med Univ, Dept Pathol, Affiliated Hosp 1, Chongqing 400016, Peoples R China"

通信作者："Yang, L (通讯作者)，Chongqing Med Univ, Dept Hematol, Affiliated Hosp 1, 1 You Yi Rd, Chongqing 400016, Peoples R China."

来源：ANNALS OF HEMATOLOGY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001004539400001

JCR分区：Q2

影响因子：3

年份：2023

卷号：102

期号：8

开始页：2153

结束页：2163

文献类型：Article

关键词：Primary central nerves system lymphoma; Prognostic factors; Cerebrospinal fluid; Interleukin-10

摘要："Primary central nervous system lymphoma (PCNSL) is special extranodal malignant non-Hodgkin lymphomas. This study analyzed clinical features and prognostic factors of PCNSL and evaluated the difference of interleukin (IL) concentrations in cerebrospinal fluid (CSF) between PCNSL and systemic non-Hodgkin lymphoma (sNHL). Patients consecutive newly diagnosed with PCNSL were recruited, the demographic and clinicopathological data were retrospectively analyzed, and the potential prognostic factors for overall survival (OS) were identified with survival analysis. 27 patients with PCNSL and 21 patients with sNHL collected CSF IL-5, IL-6, and IL-10 concentrations at diagnosis. The difference in interleukin (IL) concentrations in two diseases was analyzed to evaluate the value of IL concentrations. A total of 64 patients with PCNSL were enrolled, the median age was 54.50 years (range 16-85 years); male: female ratio was 1.91. Headache was the most common complaint symptom involved in 42.19% (27/64) of patients. Diffuse large B-cell lymphoma (DLBCL) accounted for 89.06% (57/64) of patients; other uncommon types accounted for 3.13% (2/64). In prognostic analysis, multiple lesions and Ki67 >= 75% expression exhibited a worse prognosis(P = 0.041), and patients with autologous hematopoietic stem cell transplantation (auto-HSCT) treatment presented superior OS (P < 0.05). In multivariate analysis, BCL2 expression was revealed as an unfavorable prognostic marker, and auto-HSCT was revealed as a favorable prognostic marker. CSF IL-10 concentration in patients with PCNSL was significantly higher than sNHL (P = 0.000) and excluded other histopathology of NHL; IL-10 value was still significantly different between DLBCL of PCNSL and sDLBCL (P = 0.003). In ROC curve analysis, the cutoff value of IL-10 was 0.43 pg/mL for the diagnosis value of PCNSL, sensitivity was 96.3%, specificity was 66.67%, and AUC was 0.84 (0.71-0.96). Although IL-6 concentration did not differ in the two groups, IL-10/IL-6 ratio was meaningful, with a cutoff value of 0.21, sensitivity of 81.48%, specificity of 80.95%, and AUC of 0.83 (0.71-0.95). This study highlights the characteristics of patients with PCNSL, potential prognostic makers also have been explained. CSF interleukin (IL) concentrations revealed IL-10 levels, and IL-10/IL-6 ratio may represent a useful biomarker in the differential diagnosis of PCNSL and sNHL."

基金机构：　

基金资助正文：